Univariate analysis for disease-specific survival (DSS) showed that tumour multiplicity (multiple), serosal invasion, portal vein invasion, hepatic vein invasion, T2D history and PM of DPYSL3 were the significant risk factors for reduced survival (Table 3). This evidence concerns the gene DPYSL3 and neoplasm.